The therapeutic effects of bevacizumab in patients with polypoidal choroidal vasculopathy - Test2 - elhamkhani - TriplyDB

The therapeutic effects of bevacizumab in patients with polypoidal choroidal vasculopathy

The therapeutic effects of bevacizumab in patients with polypoidal choroidal vasculopathy

http://www.wikidata.org/entity/Q37070218

about

Polypoidal choroidal vasculopathy: an angiographic discussion.Polypoidal Choroidal Vasculopathy with Feeder Vessels: Characteristics, Fellow Eye Findings, and Long-term Treatment Outcomes.Comparison of intravitreal bevacizumab to photodynamic therapy for polypoidal choroidal vasculopathy: short-term results Intravitreal anti-vascular endothelial growth factor for typical exudative age-related macular degeneration in eyes with good baseline visual acuity.Prospective evaluation of subretinal vessel location in polypoidal choroidal vasculopathy (PCV) and response of hemorrhagic and exudative PCV to high-dose antiangiogenic therapy (an American Ophthalmological Society thesis).Development of polypoidal lesions in age-related macular degeneration Effects of three consecutive monthly intravitreal injection of ranibizumab for polypoidal choroidal vasculopathy in Korea.Clinical Outcomes of Eyes with Submacular Hemorrhage Secondary to Age-related Macular Degeneration Treated with Anti-vascular Endothelial Growth Factor.Intravitreal Anti-vascular Endothelial Growth Factor for Newly Diagnosed Symptomatic Polypoidal Choroidal Vasculopathy with Extrafoveal Polyps.Optical Coherence Tomography-based Diagnosis of Polypoidal Choroidal Vasculopathy in Korean Patients Intravitreal Anti-vascular Endothelial Growth Factor for Treating Polypoidal Choroidal Vasculopathy with Grape-like Polyp Clusters.One-year results of intravitreal ranibizumab with or without photodynamic therapy for polypoidal choroidal vasculopathy.Photodynamic therapy combined with intravitreal injection of vascular endothelial growth factor antibody for polypoidal choroidal vasculopathy.Treatment of Bilateral Retinal Angiomatous Proliferation with Anti-vascular Endothelial Growth Factor: 12-Month Outcome.Disadvantages of photodynamic therapy for polypoidal choroidal vasculopathy.Anti-vascular endothelial growth factor drugs in polypoidal choroidal vasculopathy.Polypoidal choroidal vasculopathy treatment options: A meta-analysis.Three-year follow-up results of photodynamic therapy for polypoidal choroidal vasculopathy.Photodynamic therapy for polypoidal choroidal vasculopathy.

P2860

Q33523990-74C369F7-D4B3-45F1-9F6B-10109EB259C5 Q33794644-D51B3DB4-4C2A-47EE-9D6F-65E10CFBCB94 Q34007126-CD7B2C33-9497-4F4B-B47B-1298A0D250A4 Q34551927-AD0666C1-4F27-4126-9A21-0913F0FF44E2 Q35018542-78616823-27DE-43F1-92FC-E4439B8274D8 Q35208778-83AD3791-9F01-4F60-AD50-2D587E4F9BD3 Q35549978-E0750A00-180F-44C7-B803-E5307AE46816 Q36127278-4F3FECB5-BAB9-4DF2-AD1B-A49257C6D68A Q36343000-E9322E46-3830-4BED-88FF-B62B9F45FD1A Q36932315-60B659AA-517B-47F3-9BFD-69FA00F0A2F8 Q37136866-F402B5E7-5FC0-43E7-A099-C2BA1CC0A314 Q37901282-8C50A6E2-CA8F-47F2-9909-99CDF7F87BAD Q38477676-21700827-E5A9-424D-82B1-1BCAC095A8B6 Q42204337-577EFFEE-022B-423D-A7BF-B23036A05A70 Q42340519-80B31E1B-3559-4A32-8A06-9DDCDB26CE91 Q42767901-0CC08302-58F7-458E-B38A-D0BBC97830A1 Q48239027-53787FB1-9C78-4ADA-8220-1D79F484D6B8 Q50526503-E9837519-2D7C-4BAC-8B0C-C30161F136AC Q50544508-45E63502-8B99-49C4-A2E1-3F14E695B2AC

P2860

The therapeutic effects of bevacizumab in patients with polypoidal choroidal vasculopathy

http://www.wikidata.org/entity/Q37070218

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on June 2008

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

The therapeutic effects of bevacizumab in patients with polypoidal choroidal vasculopathy

@en

The therapeutic effects of bev ...... poidal choroidal vasculopathy.

@nl

type

label

The therapeutic effects of bevacizumab in patients with polypoidal choroidal vasculopathy

@en

The therapeutic effects of bev ...... poidal choroidal vasculopathy.

@nl

prefLabel

The therapeutic effects of bevacizumab in patients with polypoidal choroidal vasculopathy

@en

The therapeutic effects of bev ...... poidal choroidal vasculopathy.

@nl

P1433

Q37070218-EEF0FAAC-F07C-4BB2-B3AE-E6A4A0F2D1E8

P1476

Q37070218-2F5FE25C-9706-438D-90BD-83B3EA78BB89

P2093

Q37070218-74A67DAF-1A40-435D-B4B1-AD3F8D73A51F

Q37070218-7A10E928-491B-4A1B-8BAB-042E5CAAC83C

Q37070218-7B5F1417-24CF-4645-ACF5-4BD5510DB067

Q37070218-84481E1D-8A35-4482-A172-34570A28587B

Q37070218-EFA3E80A-EE1D-4312-9C44-C2AC12B2E65B

P2860

Q37070218-086B1418-AC88-4D22-B3EC-990F65A0A401

Q37070218-095DE898-CB7F-4285-908D-D8E27C517A25

Q37070218-203D3F26-E1FE-4B50-B18C-E9EAB3763431

Q37070218-219CA40D-2023-41F9-AF73-69E79E915AE0

Q37070218-240BA4C3-ADBF-4B41-B70F-4063883CF384

Q37070218-26F6A202-D021-4CFF-9C96-DB9A3DE8959E

Q37070218-29BC8664-5AF0-4553-8EEC-52ECB0CCD7E5

Q37070218-320E3818-C152-4ACD-872C-2BB0C78FE2BD

Q37070218-347D7C29-1FD0-4E97-B32C-828102CDDB28

Q37070218-3C0C20AA-08EB-40B9-B9E1-10FFA11E73EE

P304

Q37070218-B89D2C08-734B-4E2B-BE6A-37D2D56CB0F1

P31

Q37070218-546E74DF-D8D9-4BC9-8FC0-DA7948A4C8CE

P356

Q37070218-4409AAA9-0BB8-44FC-9DF9-F0748B2DEF17

P433

Q37070218-10CE8143-C72E-46B3-9212-510C45F7C2BE

P478

Q37070218-E170C15A-4C86-41CA-9D45-3B6750A24C66

P577

Q37070218-61478FB6-D995-4F05-A8DD-8C1DF05F51E2

P5875

Q37070218-FAEFFBC8-677F-4DB3-AB3D-D6CA903B2F8A

P698

Q37070218-C6F12CF4-2B3D-4A0F-B002-EBE9FB3CAF35

P921

Q37070218-9EE5F2F1-95D7-4205-8D0B-FABF8FB288F0

Q37070218-D007D647-7C96-43B5-BAF8-00932197DDE6

P932

Q37070218-35F8A7BF-FD7E-42EC-B318-B90FE450A2D4

P356

KJO.2008.22.2.92

P1433

Korean Journal of Ophthalmology

P1476

The therapeutic effects of bevacizumab in patients with polypoidal choroidal vasculopathy

@en

P2093

Hyewon Chung

http://www.w3.org/2001/XMLSchema#string

June Gone Kim

http://www.w3.org/2001/XMLSchema#string

Soo Geun Joe

http://www.w3.org/2001/XMLSchema#string

Sun Young Lee

http://www.w3.org/2001/XMLSchema#string

Young Hee Yoon

http://www.w3.org/2001/XMLSchema#string

P2860

Surgical treatment of submacular hemorrhage associated with idiopathic polypoidal choroidal vasculopathy.

Photodynamic therapy with verteporfin for symptomatic polypoidal choroidal vasculopathy: one-year results of a prospective case series.

Polypoidal choroidal vasculopathy in Caucasians.

Polypoidal choroidal vasculopathy.

A study of laser photocoagulation for polypoidal choroidal vasculopathy.

Idiopathic polypoidal choroidal vasculopathy of the macula.

Optical coherence tomography findings after an intravitreal injection of bevacizumab (avastin) for neovascular age-related macular degeneration.

Verteporfin therapy combined with intravitreal triamcinolone in all types of choroidal neovascularization due to age-related macular degeneration.

Photodynamic therapy with verteporfin in the treatment of exudative idiopathic polypoidal choroidal vasculopathy.

Treatment of polypoidal choroidal vasculopathy with photodynamic therapy.

P304

92-99

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3341/KJO.2008.22.2.92

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

22

http://www.w3.org/2001/XMLSchema#string

P577

2008-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5239044

http://www.w3.org/2001/XMLSchema#string

P698

18612226

http://www.w3.org/2001/XMLSchema#string

P921

P932

2629943

http://www.w3.org/2001/XMLSchema#string